Macular corneal dystrophy
Therapeutic area
Neurology
Rare disease
Yes
- Definition
- Macular corneal dystrophy (MCD) is a rare, severe form of stromal corneal dystrophy characterized by bilateral ill-defined cloudy regions within a hazy stroma, and eventually severe visual impairment.
- Genetic basis
- Yes
- Non-human condition
- No
- Rare disease
- Yes
- Listing at source
- Listed
- Condition name
- Macular corneal dystrophy
- Therapeutic area
- Neurology
- macular corneal dystrophy
- corneal dystrophy Groenouw type II
- Fehr corneal dystrophy
- Macular Dystrophy, Corneal
- Macular dystrophy, corneal type 1
- MCD
- Groenouw type II corneal dystrophy
- macular corneal dystrophy type 1
- Mcdc1
- Severity
- Severe
- Genetic
- Hereditary
Sources for recorded values
- Neurology
- Ophthalmology
Sources for recorded values
- MONDO ID
- MONDO:0009020
- Parent condition
- MONDO:0020213
Related records
Broader conditions (18)
- Corneal disorder
- Corneal dystrophy
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Disease of genetic or genomic mechanism
- Disorder of orbital region
- Disorder of visual system
- Eye disorder
- Hereditary disease
- Hereditary macular dystrophy
- Hereditary neurological disease
- Human disease
- Inherited retinal dystrophy
- Nervous system disorder
- Retinal degeneration
- Retinal disorder
- Stromal corneal dystrophy
Trials (22)
- A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease
- A Study to Evaluate the Safety, Tolerability and PK of SK-09
- An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
- Atacicept in Multiple Glomerular Diseases
- Cardiac Autonomic Function in Women with Microvascular Coronary Dysfunction
- Castleman Disease Collaborative Network Biobank
- Combined Malonic and Methylmalonic Aciduria (CMAMMA): Gene Identification and Outcome Study
- Fresh Corneal Lenticule Implantation in Macular Corneal Distrophy With Relex Smile Surgery
- Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome
- International Registry for Patients With Castleman Disease
- Nephrotic Syndrome Study Network
- NEPTUNE Match Study
- Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
- Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi
- Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease
- Steroid Treatment for Kidney Disease
- Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy
- The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
- Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease